Literature DB >> 10624884

Sinitang (Shigyaku-to), a traditional Chinese medicine improves microcirculatory disturbances induced by endotoxin in rats.

H Zhang1, Y Sugiura, Y Wakiya, Y Goto.   

Abstract

The present study investigated the effects of Sinitang (Japanese name: Shigyaku-to--a traditional Chinese medicine), on microcirculatory disturbances induced by endotoxin in rat mesentery. The changes of arteriolar diameter, the velocity of red blood cells in arterioles and venular microcirculation after endotoxin injection (6 mg x kg(-1), i.v.) were observed by videomicroscopy. Mean arterial pressure and heart rate were monitored continuously during the experiments. Sinitang significantly prevented the decrease of mean arterial pressure, controlled the reduced velocity and also, apparently inhibited the leukocyte extravasation across venules. However, there were no significant changes in the arteriolar diameter and the heart rate in all groups treated with or without Sinitang. The results indicate that Sinitang has protective effects to improve the microcirculatory disturbances induced by endotoxin in rat mesentery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10624884     DOI: 10.1016/s0378-8741(99)00114-2

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  2 in total

1.  Cardiovascular Disease Chemogenomics Knowledgebase-guided Target Identification and Drug Synergy Mechanism Study of an Herbal Formula.

Authors:  Hai Zhang; Shifan Ma; Zhiwei Feng; Dongyao Wang; Chengjian Li; Yan Cao; Xiaofei Chen; Aijun Liu; Zhenyu Zhu; Junping Zhang; Guoqing Zhang; Yifeng Chai; Lirong Wang; Xiang-Qun Xie
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

2.  Sini Decoction Improves Adrenal Function and the Short-Term Outcome of Septic Rats through Downregulation of Adrenal Toll-Like Receptor 4 Expression.

Authors:  Fang Lai; Gengbiao Zhou; Shutao Mai; Xiaolian Qin; Wenting Liu; Yan Zhang; Dongping Xie; Yanna Weng; Jiongdong Du; Yi Zheng; Jiyang Liao; Yun Han
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-19       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.